A Peter Mac-led international clinical trial has found a way to personalize treatment for gastroesophageal cancer, ...

Subcutaneous pembrolizumab reduces time demands for both the patient and clinician, all while providing a consistent efficacy ...

This week Bobbi Conner talks with Dr. Miriam Alexander about advances in lung cancer treatment in recent years. Dr. Alexander ...

BNT327 combined with chemotherapy showed an overall response rate of 85.4% when used as a first-line treatment for ...

The radioligand agent is now approved for use before chemotherapy in patients who have been treated with an androgen receptor pathway inhibitor.

The addition of nivolumab to neoadjuvant chemotherapy significantly increased pathologic complete response among certain patients with breast cancer, according to findings published in Nature Medicine ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy for oncologists treating patients in a community setting.

A 59-year-old British woman preparing for the funeral of her mother who died of breast cancer was diagnosed with the same disease within a week. According to Sue, she had first noticed redness and ...

Mercy Health’s oncology program is one of eight in the U.S. to take part in a clinical trial to reduce hair loss in breast ...

Elena Adams said she was put on temozolomide within days of being diagnosed with a brain tumour in 2016. Guidelines say the ...